Serum leptin levels are associated with tamoxifen-induced hepatic steatosis


Gunel N., Coskun U., Toruner F., Sancak B., Yilmaz E., Cengiz O., ...More

CURRENT MEDICAL RESEARCH AND OPINION, vol.19, no.1, pp.47-50, 2003 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 19 Issue: 1
  • Publication Date: 2003
  • Doi Number: 10.1185/030079902125001308
  • Title of Journal : CURRENT MEDICAL RESEARCH AND OPINION
  • Page Numbers: pp.47-50

Abstract

Purpose: Tamoxifen, used in breast cancer treatment, may induce hepatic steatosis. It has been suggested that leptin, which, has a relationship with body fat stores, may be involved in the pathogenesis of hepatic steatosis. In this study, we compared serum leptin levels in tamoxifen-treated patients with and without hepatic steatosis.